Olfr69, encoded by the Or52a5b gene, is a member of the olfactory receptor family in Mus musculus, belonging to the G-protein-coupled receptor (GPCR) superfamily. These receptors play a vital role in the sense of smell, detecting odorant molecules in the nasal epithelium and initiating neuronal responses that lead to olfactory perception. Structurally, olfactory receptors, including Olfr69, share a 7-transmembrane domain characteristic of many neurotransmitter and hormone receptors, and they are responsible for recognizing odorants and initiating G protein-mediated signal transduction. The activation of these receptors by specific odorants triggers various intracellular events, often involving the modulation of second messengers like cyclic AMP (cAMP). Given the complexity of GPCR signaling pathways and the lack of well-characterized direct inhibitors, the focus shifts to potential indirect inhibitors that modulate related signaling pathways or cellular processes. Beta-adrenergic receptor antagonists, such as propranolol, atenolol, and metoprolol, reduce cellular cAMP levels, a critical component in GPCR signaling. This reduction in cAMP may indirectly affect the signaling pathways of GPCRs, potentially influencing the function of olfactory receptors like Olfr69. Calcium channel blockers, such as nifedipine and verapamil, alter intracellular calcium levels, another key factor in GPCR signaling. Changes in calcium dynamics can indirectly affect the function of GPCRs, including olfactory receptors.
Additionally, targeting other GPCR pathways, such as those modulated by angiotensin II receptors, offers an indirect method to modulate olfactory receptor function. Antagonists like losartan and candesartan might alter the GPCR signaling environment, potentially affecting receptors like Olfr69. Alpha-2 adrenergic receptor modulation by agents like yohimbine and clonidine could also indirectly impact GPCR signaling mechanisms, including those of olfactory receptors. In summary, the indirect inhibition of Olfr69 involves an understanding of GPCR biology and the interconnected nature of cellular signaling pathways. The chemicals listed provide insights into potential mechanisms for influencing the activity of olfactory receptors like Olfr69. While direct inhibition remains a significant challenge, these indirect approaches offer potential strategies for modulating the receptor's function within the complex network of GPCR signaling.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Propranolol | 525-66-6 | sc-507425 | 100 mg | $180.00 | ||
Propranolol, a non-selective beta-adrenergic antagonist, reduces cAMP levels by inhibiting beta-adrenergic receptors, potentially affecting GPCR-mediated pathways relevant to Olfr69. | ||||||
(RS)-Atenolol | 29122-68-7 | sc-204895 sc-204895A | 1 g 10 g | $77.00 $408.00 | 1 | |
Atenolol, a β1-adrenergic receptor antagonist, decreases cAMP levels, potentially indirectly influencing GPCR signaling pathways and impacting Olfr69 function. | ||||||
Metoprolol Tartrate | 56392-17-7 | sc-205751 sc-205751A | 5 g 25 g | $105.00 $238.00 | 3 | |
Metoprolol, a β1-adrenergic receptor blocker, may indirectly affect GPCR signaling by altering β1 receptor activity, potentially impacting Olfr69. | ||||||
Nifedipine | 21829-25-4 | sc-3589 sc-3589A | 1 g 5 g | $58.00 $170.00 | 15 | |
Nifedipine, a calcium channel blocker, modulates intracellular calcium levels, potentially impacting GPCR-mediated pathways and indirectly affecting Olfr69. | ||||||
Verapamil | 52-53-9 | sc-507373 | 1 g | $367.00 | ||
Verapamil, a calcium channel blocker, can indirectly influence GPCR signaling through altered calcium dynamics, potentially impacting Olfr69. | ||||||
Carvedilol | 72956-09-3 | sc-200157 sc-200157A sc-200157B sc-200157C sc-200157D | 100 mg 1 g 10 g 25 g 100 g | $122.00 $235.00 $520.00 $979.00 $1500.00 | 2 | |
Carvedilol, with beta-adrenergic antagonist and alpha-1 blocking activity, might modulate GPCR-mediated signaling, potentially influencing Olfr69. | ||||||
Losartan | 114798-26-4 | sc-353662 | 100 mg | $127.00 | 18 | |
Losartan, an angiotensin II receptor antagonist, affects GPCR signaling by inhibiting AT1 receptors, potentially indirectly impacting Olfr69. | ||||||
Candesartan | 139481-59-7 | sc-217825 sc-217825B sc-217825A | 10 mg 100 mg 1 g | $46.00 $92.00 $148.00 | 6 | |
Candesartan, an angiotensin II receptor blocker, could indirectly modulate GPCR signaling pathways, influencing Olfr69. | ||||||
Yohimbine hydrochloride | 65-19-0 | sc-204412 sc-204412A sc-204412B | 1 g 5 g 25 g | $50.00 $168.00 $520.00 | 2 | |
Yohimbine, an alpha-2 adrenergic receptor antagonist, can indirectly affect GPCR signaling, potentially influencing Olfr69. | ||||||
Nadolol | 42200-33-9 | sc-253175 | 1 g | $180.00 | ||
Nadolol, a non-selective beta-adrenergic receptor blocker, indirectly influences GPCR signaling, which could impact Olfr69. |